Picture of Infant Bacterial Therapeutics AB logo

IBT B — Infant Bacterial Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Infant Bacterial Therapeutics Updates On Phase III Study Of IBP-9414

Sept 2 (Reuters) - Infant Bacterial Therapeutics AB
(publ)  IBTb.ST :
    * SAID ON FRIDAY PHASE III STUDY OF IBP-9414, BACTERIAL
STRAIN
FOUND NATURALLY IN HUMAN BREAST MILK, SHOWS NO SIGNIFICANT
EFFECTS ON PRIMARY ENDPOINTS 
    * BUT STUDY SHOWS SIGNIFICANT REDUCTION IN SECONDARY
ENDPOINT,
ALL-CAUSE MORTALITY

        
 Source text for Workspace:  urn:newsml:reuters.com:*:nMFN7P92s4
 Further company coverage:  IBTb.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Infant Bacterial Therapeutics AB

See all news